analgesic/vomiting

FIELD OF THE INVENTION The present invention relates to an analgesic formulation for pain control not limited to postoperative pain control. BACKGROUND OF THE INVENTION The treatment and relief of pain is one of the most common reasons patients seek medical evaluation. Pain has been defined by the

BACKGROUND OF THE INVENTION The administration of therapeutic doses of morphine and other clinically useful narcotic analgesics is often accompanied by unpleasant side effects on the gastro-intestinal system. For instance, morphine and related opiates such as meperidine and methadone may retard

BACKGROUND The administration of therapeutic doses of morphine and other clinically useful narcotic analgesics is often accompanied by unpleasant side effects on the gastro-intestinal system. For instance, morphine and related opiates such as meperidine and methadone may retard intestinal mobility

BACKGROUND OF THE INVENTION Morphine or other bimodally-acting opioid agonists are administered to relieve severe pain due to the fact that they have analgesic effects mediated by their activation of inhibitory opioid receptors on nociceptive neurons (see North, Trends Neurosci., Vol. 9, pp. 114-117

This invention relates generally to methods for reducing, treating, reversing or preventing drug-mediated respiratory depression, such as may be directly or indirectly caused by use of various bioactive compositions, including anaesthetics, barbiturates, analgesics, etc. The invention further

TECHNICAL FIELD This invention relates to novel tetrazolyl-substituted quinuclidine compounds and their pharmaceutically acceptable salts, pharmaceutical compositions containing such compounds, and the use of such compounds as substance P antagonists. BACKGROUND ART Substance P is a naturally

BACKGROUND OF THE INVENTION The present invention relates to piperidine derivatives, to processes for their preparation, to pharmaceutical compositions containing them and to their medical use. In particular the invention relates to novel compounds which are potent and specific antagonists of

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention is relevant to the field of suppressing sensory afferent neuron mediated symptoms and the manufacture of agents and compositions which suppress the same. 2. Discussion of the Related Art. Sensory afferent nerves mediate a

TECHNICAL FIELD The present invention relates to a novel biaryl benzoimidazole derivative, a method for preparing the same, and a pharmaceutical composition comprising the same, in which the biaryl benzoimidazole derivative functions as an antagonist of the vanilloid receptor (Capsaicin receptor;

The present invention relates to new derivatives of 1-phenyl-3-azabicycloalkyl-imidazolidin-2-ones, to a process for their preparation, to pharmaceutical compositions containing them and to their use as therapeutic agents. The present invention provides novel compounds having the general formula (I)

The present invention relates to new derivatives of 1-phenyl-3-azabicycloalkyl-imidazolidin-2-ones, to a process for their preparation, to pharmaceutical compositions containing them and to their use as therapeutic agents. The present invention provides novel compounds having the general formula (I)

The present invention relates to new derivatives of 2,3,3a,4-Tetrahydro-2-azabicycloalkyl-1H-imidazo [5,1-c][1,4]benzoxazin-1-one, to a process for their preparation, to pharmaceutical compositions containing them and to their use as therapeutic agents. The present invention provides novel compounds

BACKGROUND OF THE INVENTION This invention relates to certain novel octahydro-3-alkoxy-9-alkyl-phenanthridines and derivatives thereof and pharmaceutically acceptable acid addition salts thereof useful as antiinflammatory, analgesics, immunosuppressive, antiemetic and intraocular pressure reducing